多期增强CT强化模式预测胃癌同时性及异时性肝转移
回顾性纳入125例晚期胃癌患者,分析原发灶多期增强CT强化模式与同时性(11例)、异时性(5例)肝转移的关系。同时性和异时性肝转移多表现为动脉期或门脉期峰值强化伴延迟期低强化(廓清),该特征有助于影像监测。
要点
- 胃癌同时性和异时性肝转移原发灶多呈动脉期或门脉期峰值强化伴延迟期廓清。
- 以峰值强化预测同时性肝转移,阅片者1敏感度72.7%、特异度89.3%,阅片者2敏感度54.5%、特异度94.6%。
核心结论
- 胃癌伴同时性或异时性肝转移倾向表现为增强CT早期强化伴廓清模式,该特征有助于对胃癌同时性或异时性肝转移进行影像监测。
研究设计与样本
- 回顾性研究,纳入2013年1月至2016年7月在本机构经胃镜和增强CT评估的125例晚期胃癌患者,由两名放射科医师独立阅片,确定峰值强化期并测量各期胃病灶CT衰减值。
关键影像表现/征象
- 同时性和异时性肝转移灶原发灶多表现为动脉期或门脉期峰值强化。
- 延迟期CT衰减值:同时性和异时性肝转移组高于无肝转移组(阅片者1 P=0.0003,阅片者2 P=0.0002)。
- 峰值强化在三组间差异有统计学意义(阅片者1 P=0.0001,阅片者2 P=0.0002)。
诊断标准与关键数值
- 以峰值强化预测同时性肝转移:阅片者1敏感度72.7%、特异度89.3%、阳性预测值57.1%、阴性预测值94.3%、准确率86.6%;阅片者2敏感度54.5%、特异度94.6%、阳性预测值66.7%、阴性预测值91.4%、准确率88.1%。
- 以峰值强化预测异时性肝转移:阅片者1敏感度60.0%、特异度89.3%、阳性预测值33.0%、阴性预测值94.3%、准确率86.9%;阅片者2敏感度40.0%、特异度94.6%、阳性预测值40.0%、阴性预测值94.6%、准确率90.2%。
临床应用与阅片要点
- 阅片时关注胃癌原发灶的峰值强化期,动脉期或门脉期峰值强化伴延迟期廓清提示可能伴发或术后发生肝转移。
- 同时性肝转移11例,异时性肝转移5例(中位随访313天),无肝转移56例(中位随访1102天)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study was to examine the relationship between the CT features of the primary-site gastric cancer and the concurrent existence or postoperative recurrence of hepatic metastasis.
MATERIALS AND METHODS: From January 2013 to July 2016, 125 patients with advanced gastric cancer who were evaluated by gastroscopy and contrast-enhanced CT at our institution were included. Eleven patients had hepatic metastasis at the time of diagnosis (synchronous hepatic metastasis). Five patients had hepatic recurrence after surgery (metachronous hepatic metastasis, median follow-up period of 313 days), and another 56 patients had no hepatic recurrence during follow-up period (negative hepatic metastasis, median follow-up period of 1102 days). Two radiologists independently reviewed the CT images and they determined the peak enhancement phase, and then measured the CT attenuation value of the gastric lesion for each phase. We compared the parameters of synchronous, metachronous and negative hepatic-metastasis. We calculated diagnostic performance of CT for diagnosing synchronous and metachronous hepatic metastasis.
RESULTS: The peak enhancement was significantly diff ;erent between the three groups for both readers (reader 1, p = 0.0001; reader 2, p = 0.0002). Most of the synchronous and metachronous hepatic metastasis had peak enhancement in the arterial or portal phase. The CT attenuation values of synchronous and metachronous hepatic metastasis were significantly higher than those of negative hepatic metastasis in the delayed phase according to both readers (reader 1, p = 0.0003; reader 2, p = 0.0002). In predicting synchronous hepatic metastasis using peak enhancement, the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were 72.7%, 89.3%, 57.1%, 94.3%, and 86.6% for reader 1, and 54.5%, 94.6%, 66.7%, 91.4%, and 88.1% for reader 2. In predicting metachronous hepatic metastasis, the sensitivity, specificity, PPV, NPV, and accuracy were 60.0%, 89.3%, 33.0%, 94.3%, and 86.9% for reader 1, and 40.0%, 94.6%, 40.0%, 94.6%, and 90.2% for reader 2.
CONCLUSION: Our study showed that gastric cancer with synchronous and metachronous hepatic metastasis tends to show early enhancement with a washout pattern on contrast-enhanced CT. This feature would be helpful in image surveillance for synchronous or metachronous hepatic metastasis of gastric cancer.
引用
- Tsurumaru D, Nishimuta Y, Muraki T, et al. Gastric cancer with synchronous and metachronous hepatic metastasis predicted by enhancement pattern on multiphasic contrast-enhanced CT. Eur J Radiol. 2018. PMID: 30396650. doi:10.1016/j.ejrad.2018.09.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。